Clinical Trial: A Study to Evaluate the Efficacy and Safety of Proximod in Patients With Rheumatoid Arthritis

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07856511) titled 'A Study to Evaluate the Efficacy and Safety of Proximod in Patients With Rheumatoid Arthritis' on Sept. 28.

Brief Summary: This study is to evaluate the efficacy and safety of different doses of proximod in moderate-to-severe active rheumatoid arthritis subjects with inadequate response or intolerance to bDMARDs and/or tsDMARDs

Study Start Date: Oct. 15

Study Type: INTERVENTIONAL

Condition: Rheumatoid Arthrits

Intervention: DRUG: Placebo

The placebo group will take drugs orally for 16 weeks, and then were randomly assigned to proximod dose 1 and proximod dose 2 for 36 weeks, in the meanwhile, proximod dose 1 group and proximod...